Ioxaglic acid

Ioxaglic acid

Systematic (IUPAC) name
3-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodo-5-(2-{[2,4,6-triiodo-3-(methylcarbamoyl)-5-(N-methylacetamido)phenyl]formamido}acetamido)benzoic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
ATC code	V08AB03 (WHO)
PubChem	CID 3742
ChemSpider	3611
UNII	Z40X7EI2AF
KEGG	D01761
ChEMBL	CHEMBL1201291
Chemical data
Formula	C24H21I6N5O8
Molar mass	1268.87906 g/mol
SMILES CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I
InChI InChI=1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) Key:TYYBFXNZMFNZJT-UHFFFAOYSA-N

Ioxaglic acid (trade name Hexabrix) is an iodine containing molecule used as a low-osmolality contrast medium.^[1]

References

1. Meijenhorst, G. C.; De Bruin, J. N. (1980). "Hexabrix (ioxaglate), a new low osmolality contrast agent for lumbar epidural double-catheter venography". Neuroradiology 20 (1): 29–32. PMID 6999377.